Synthesis of N-acetyl-S-(3-coumarinyl)-cysteine methyl ester and HPLC analysis of urinary coumarin metabolites

Toxicology

Volumn 190, Issue 3, 2003, Pages 249-258

  Eisenbrand, Gerhard ^a   Otteneder, Michael ^a   Tang, Weici ^a  

^a France   (Germany)

Author keywords

Coumarin; HPLC determination; Metabolism; N Acetyl S (3 coumarinyl)cysteine; Synthesis

Indexed keywords

COUMARIN;

ARTICLE; DRUG DETERMINATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SEPARATION TECHNIQUE; URINE;

RODENTIA;

EID: 0042133168     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00204-X     Document Type: Article

References (35)

1. Beckley-Kartey S.A., Hotchkiss S.A., Capel M. Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse. Toxicol. Appl. Pharmacol. 145:1997;34-42.
2. Bogan D.P., Deasy B., O'Kennedy R., Smyth M.R., Fuhr U. Determination of free and total 7-hydroxycoumarin in urine and serum by capillary electrophoresis. J. Chromatogr. B. Biomed. Appl. 663:1995;371-378.
3. Bogan D.P., Deasy B., O'Kennedy R., Smyth M.R. Interspecies differences in coumarin metabolism in liver microsomes examined by capillary electrophoresis. Xenobiotica. 26:1996;437-445.
4. Born S.L., Rodriguez P.A., Eddy C.L., Lehman-McKeeman L.D. Synthesis and reactivity of coumarin 3,4-epoxide. Drug Metab. Dispos. 25:1997;1318-1324.
5. Brogden P.J., Gabbutt C.D., Hepworth J.D. Pyrans and fused pyrans. Katritzky A.R., Rees C.W. Comprehensive Heterocyclic Chemistry. 1974;573-810 Pergamon Press, Oxford, New York, Toronto.
6. Burgos A., Alcaide A., Alcoba C., Azcona J.M., Garrido J., Lorente C., Moreno E., Murillo E., Olsina-Pavia J., Olsina-Kissler J., Samaniego E., Serra M. Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology. 32:1999;3-10.
7. Cohen A.J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance in man. Food Chem. Toxicol. 17:1979;277-289.
8. Duffy C.F., O'Kennedy R. Determination of 7-hydroxycoumarin and its glucuronide and sulphate conjugates in liver slice incubates by capillary zone electrophoresis. J. Pharm. Biomed. Anal. 17:1998;1279-1284.
9. Fentem J.H., Fry J.R. Species differences in the metabolism and hepatotoxicity of coumarin. Comp. Biochem. Physiol. C. 104:1993;1-8.
10. 14C]coumarin by rats and by human volunteers under simulated conditions of use in fragrances. Food Chem. Toxicol. 39:2001;153-162.
11. Graf A.H., Graf B., Brandis M.G., Kogelnik H.D., Staudach A., Traun H. Oral Anticoagulation in patients with gynecological cancer and radiotherapy: a retrospective analysis of 132 patients. Anticancer Res. 18B:1998;2047-2051.
12. Hadidi H., Zahlsen K., Idle J.R., Cholerton S. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem. Toxicol. 35:1997;903-907.
13. Hadidi H., Irshaid Y., Vagbo C.B., Brunsvik A., Cholerton S., Zahlsen K., Idle J.R. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6. Eur. J. Clin. Pharmacol. 54:1998;437-441.
14. Hallas G. Esterification of aromatic acids with boron trifluoride-methanol. J. Chem. Soc. 1965;5770-5771.
15. Huwer T., Altmann H.J., Grunow W., Lenhardt S., Przybylski M., Eisenbrand G. Coumarin mercapturic acid isolated from rat urine indicates metabolic formation of coumarin 3,4-epoxide. Chem. Res. Toxicol. 4:1991;586-590.
16. Lake B.G. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem. Toxicol. 37:1999;423-453.
17. Lake B.G., Sauer M.J., Esclangon F., Beamand J.A., Price R.J., Walters D.G. Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes. Xenobiotica. 25:1995;133-141.
18. Li Y., Li N.Y., Sellers E.M. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes. Eur. J. Drug Metab. Pharmacokinet. 22:1997;295-304.
19. Loprinzi C.L., Kugler J.W., Sloan J.A., Rooke T.W., Quella S.K., Novotny P., Mowat R.B., Michalak J.C., Stella P.J., Levitt R., Tschetter L.K., Windschitl H. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. New Engl. J. Med. 340:1999;346-350.
20. Lovell D.P., van Iersel M., Walters D.G., Price R.J., Lake B.G. Genetic variation in the metabolism of coumarin in mouse liver. Pharmacogenetics. 9:1999;239-250.
21. Mackie A., Misra A.L. Preparation of rhodanine derivatives as possible anthelmintics. J. Chem. Soc. 1954;3919-3922.
22. Marshall M.E., Mohler J.L., Edmonds K., Williams B., Butler K., Ryles M., Weiss L., Urban D., Bueschen A., Markiewicz M. An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin. J. Cancer Res. Clin. Oncol. (Suppl). 120:1994;39-42.
23. Meineke I., Desel H., Kahl R., Kahl G.F., Gundert-Remy U. Determination of 2-hydroxyphenylacetic acid (2HPAA) in urine after oral and parenteral administration of coumarin by gas-liquid chromatography with flame-ionization detection. J. Pharm. Biomed. Anal. 17:1998;487-492.
24. Oscarson M., Gullsten H., Rautio A., Bernal M.L., Sinues B., Dahl M.L., Stengard J.H., Pelkonen O., Raunio H., Ingelman-Sundberg M. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Lett. 438:1998;201-205.
25. Oscarson M., McLellan R.A., Gullsten H., Yue Q.Y., Lang M.A., Bernal M.L., Sinues B., Hirvonen A., Raunio H., Pelkonen O., Ingelman-Sundberg M. Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett. 448:1999;105-110.
26. Pearce R., Greenway D., Parkinson A. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch. Biochem. Biophys. 298:1992;211-225.
27. Price R.J., Renwick A.B., Beamand J.A., Esclangon F., Wield P.T., Walters D.G., Lake B.G. Comparison of the metabolism of 7-ethoxycoumarin and coumarin in precision-cut rat liver and lung slices. Food Chem. Toxicol. 33:1995;233-237.
28. Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics. 2:1992;227-233.
29. Sagaster P., Micksche M., Flamm J., Ludwig H. Randomised study using IFN-alpha versus IFN-a plus coumarin and cimetidine for treatment of advanced renal cell cancer. Ann. Oncol. 6:1995;999-1003.
30. Shilling W.H., Crampton R.F., Longland R.C. Metabolism of coumarin in man. Nature (London). 221:1969;664-665.
31. 14C]coumarin be human liver microsomes. Xenobiotica. 24:1994;795-803.
32. von Weymarn L.B., Murphy S.E. Coumarin metabolism by rat esophageal microsomes and cytochrome P4502A3. Chem. Res. Toxicol. 14:2001;1386-1392.
33. Xing Q.Y., Wang W.J., He D.Y. 3-Thiolcoumarin and its derivatives. Acta Chim. Sin. 45:1987;344-353.
34. Yourick J.J., Bronaugh R.L. Percutaneous absorption and metabolism of coumarin in human and rat skin. J. Appl. Toxicol. 17:1997;153-158.
35. Zhuo X., Gu J., Zhang Q.Y., Spink D.C., Kaminsky L.S., Ding X. Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice. J. Pharmacol. Exp. Ther. 288:1999;463-471.